Wiel, E.C. van der

infant group measurement study function airway treatment vmaxfrc lung function z score score nitric oxide month feno values 12 months v јmaxfrc wheeze baseline fp 200 group value signi children effect wheezy infants signi ficantly respir agonist јmaxfrc e ffect oxide nitric disease feno measurements placebo pediatr malacia thoracoabdominal compression technique symptom airway diseases inhaled ventilation difference wheezy 2 agonist administration change fi rst year expiratory 6 weeks table placebo group reduction asthma technique ficant wheeze group volume 2 agonists van der wiel result 13 weeks lung disease airway malacia coworkers lung function measurements ficantly sedation erasmus university birth department bronchodilation pulmonol propionate response birth weight v ؅maxfrc p.p.b salbutamol article weight fluence feno values